Beck Mack & Oliver’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,344
Closed -$222K 187
2022
Q1
$222K Sell
6,344
-3,424
-35% -$117K 0.01% 177
2021
Q4
$297K Sell
9,768
-3,577
-27% -$117K 0.01% 167
2021
Q3
$438K Sell
13,345
-3,608
-21% -$115K 0.01% 153
2021
Q2
$513K Buy
+16,953
New +$558K 0.01% 140

Other funds holding OGN

Beck Mack & Oliver's OGN Position: Q2 2022 in Review

Beck Mack & Oliver sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 6,344 shares — an estimated $222K sold.

Beck Mack & Oliver first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $513K in Q2 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Beck Mack & Oliver reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Beck Mack & Oliver sold 6,344 Organon & Co shares in Q2 2022, an estimated $222K.
  • Beck Mack & Oliver first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Beck Mack & Oliver's Organon & Co position peaked at $513K in Q2 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Beck Mack & Oliver's 13F filing for Q2 2022, filed 12 Aug 2022.